Xinwei Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xinwei Yang has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Chongrong Ke
National and Local United Engineering Research Center of Industrial Microbiology and Fermentation Technology, Engineering Research Center of Industrial Microbiology of Ministry of Education, College of Life Sciences, Fujian Normal University, Fujian, People’s Republic of China
9 shared publications - Jianzhong Huang
National and Local Joint Engineering Research Center of Industrial Microbiology and Fermentation Technology, College of Life Sciences, Fujian Normal University, Fuzhou 350100, China
8 shared publications Yong Tao
5 shared publicationsJianzhong Huang
4 shared publicationsChongrong Ke
2 shared publications- Fengping Wang
State Key Laboratory of Submarine Geoscience; Key Laboratory of Polar Ecosystem and Climate Change, Ministry of Education; Shanghai Key Laboratory of Polar Life and Environment Sciences; and School of Oceanography, Shanghai Jiao Tong University, Shanghai, China
2 shared publications
Latest Publications
- Open Access
- 1 December 2026
- Published by KEAI Publishing in Synthetic and Systems Biotechnology
- Vol. 14, 22-31
Two-step bioconversion of pyridoxal 5′-phosphate from pyridoxine through cofactor regeneration and pyridoxine 5′-phosphate oxidase evolution
Pyridoxal 5′-phosphate (PLP), a vital cofactor in cellular metabolism, is a high-value compound widely used in the food and pharmaceutical industries. However, the efficient biosynthesis of PLP remains a significant challenge. In this study, we established a salvage pathway for the synthesis of PLP from pyridoxine (PN) using PN kinase (PdxK) from Salmonella enterica and pyridoxine 5′-phosphate oxidase (PdxH) from Saccharomyces cerevisiae as the key enzymes. To increase economic viability, an ATP regeneration system was integrated, enabling the use of AMP and polyP as substrates instead of expensive ATP. Additionally, an O2 circulating system was incorporated to provide sufficient oxygen supply and a H2O2-free environment. PdxH was identified as the rate-limiting enzyme, so we performed directed evolution of ScPdxH through random mutagenesis coupled with high-throughput screening. The optimized mutant, ScPdxH2−3E, exhibited a 3.4-fold increase in kcat/Km compared to the wild-type enzyme. Using a two-step bioconversion process, we achieved the production of 35.2 g/L pyridoxine 5′-phosphate (PNP) with a molar conversion of 94.7%, and 21.3 g/L PLP, corresponding to a final molar conversion yield of approximately 57.5% from PN in a 1-L bioreactor. This work demonstrates an efficient, sustainable and scalable strategy for the industrial production of PLP.
- 1 December 2026
- Published by KEAI Publishing in Synthetic and Systems Biotechnology
- Vol. 14, 22-31
Open AccessTwo-step bioconversion of pyridoxal 5′-phosphate from pyridoxine through cofactor regeneration and pyridoxine 5′-phosphate oxidase evolution
Pyridoxal 5′-phosphate (PLP), a vital cofactor in cellular metabolism, is a high-value compound widely used in the food and pharmaceutical industries. However, the efficient biosynthesis of PLP remains a significant challenge. In this study, we established a salvage pathway for the synthesis of PLP from pyridoxine (PN) using PN kinase (PdxK) from Salmonella enterica and pyridoxine 5′-phosphate oxidase (PdxH) from Saccharomyces cerevisiae as the key enzymes. To increase economic viability, an ATP regeneration system was integrated, enabling the use of AMP and polyP as substrates instead of expensive ATP. Additionally, an O2 circulating system was incorporated to provide sufficient oxygen supply and a H2O2-free environment. PdxH was identified as the rate-limiting enzyme, so we performed directed evolution of ScPdxH through random mutagenesis coupled with high-throughput screening. The optimized mutant, ScPdxH2−3E, exhibited a 3.4-fold increase in kcat/Km compared to the wild-type enzyme. Using a two-step bioconversion process, we achieved the production of 35.2 g/L pyridoxine 5′-phosphate (PNP) with a molar conversion of 94.7%, and 21.3 g/L PLP, corresponding to a final molar conversion yield of approximately 57.5% from PN in a 1-L bioreactor. This work demonstrates an efficient, sustainable and scalable strategy for the industrial production of PLP.
- Open Access
Chemical Constructions, Mechanism and Biological Interpretation of Nitroreductase-Responsive Systems: From Hypoxia-Associated Imaging to Activatable Therapy
Nitroreductase (NTR)-responsive systems convert the enzymatic reduction of nitroaromatic substrates into detectable signals, molecular retention, supramolecular assembly, or therapeutic activation. Their interpretation is nevertheless complicated by the distinct catalytic properties of bacterial NTRs, experimentally introduced or engineered NTR systems, and endogenous mammalian nitro-reducing enzymes. In particular, an NTR-responsive signal in mammalian tissues should not automatically be interpreted as a direct measurement of oxygen concentration or as evidence for the activity of a single endogenous “NTR.” This review analyzes NTR-responsive systems through an integrated framework that connects catalytic source, chemical event, signal-transduction mechanism, and biological application. We first distinguish defined bacterial NTRs, engineered or experimentally introduced NTR systems, and endogenous mammalian nitro-reducing activity. We then describe the recognition, linker, and output modules used in molecular design and compare three major reaction architectures: direct reduction, reduction-triggered cleavage, and reduction-triggered retention or assembly. Photoinduced electron transfer (PET), intramolecular charge transfer (ICT), fluorescence resonance energy transfer (FRET), aggregation-induced emission (AIE), chemiluminescence, photoacoustic imaging, and fluorine nuclear magnetic resonance (19F NMR) are discussed as signal-transduction modalities rather than as independent activation mechanisms. Multi-input sensing, activatable therapy, and the validation of these systems in complex biological models are subsequently evaluated. Particular emphasis is placed on product-level confirmation, enzyme attribution, oxygen-dependent interpretation, calibration, pharmacokinetics, biodistribution, and safety. By linking chemical activation to the biochemical source of reduction and to the limitations of biological inference, this review provides criteria for selecting, validating, and translating NTR-responsive systems for hypoxia-associated imaging and activatable therapy.
Open AccessChemical Constructions, Mechanism and Biological Interpretation of Nitroreductase-Responsive Systems: From Hypoxia-Associated Imaging to Activatable Therapy
Nitroreductase (NTR)-responsive systems convert the enzymatic reduction of nitroaromatic substrates into detectable signals, molecular retention, supramolecular assembly, or therapeutic activation. Their interpretation is nevertheless complicated by the distinct catalytic properties of bacterial NTRs, experimentally introduced or engineered NTR systems, and endogenous mammalian nitro-reducing enzymes. In particular, an NTR-responsive signal in mammalian tissues should not automatically be interpreted as a direct measurement of oxygen concentration or as evidence for the activity of a single endogenous “NTR.” This review analyzes NTR-responsive systems through an integrated framework that connects catalytic source, chemical event, signal-transduction mechanism, and biological application. We first distinguish defined bacterial NTRs, engineered or experimentally introduced NTR systems, and endogenous mammalian nitro-reducing activity. We then describe the recognition, linker, and output modules used in molecular design and compare three major reaction architectures: direct reduction, reduction-triggered cleavage, and reduction-triggered retention or assembly. Photoinduced electron transfer (PET), intramolecular charge transfer (ICT), fluorescence resonance energy transfer (FRET), aggregation-induced emission (AIE), chemiluminescence, photoacoustic imaging, and fluorine nuclear magnetic resonance (19F NMR) are discussed as signal-transduction modalities rather than as independent activation mechanisms. Multi-input sensing, activatable therapy, and the validation of these systems in complex biological models are subsequently evaluated. Particular emphasis is placed on product-level confirmation, enzyme attribution, oxygen-dependent interpretation, calibration, pharmacokinetics, biodistribution, and safety. By linking chemical activation to the biochemical source of reduction and to the limitations of biological inference, this review provides criteria for selecting, validating, and translating NTR-responsive systems for hypoxia-associated imaging and activatable therapy.
- Open Access
- 29 July 2026
- Published by Springer Nature in Microbial Cell Factories
- Vol. 25 (1)
Efficient Escherichia coli platform for L-proline biosynthesis via systematic metabolic engineering
- 29 July 2026
- Published by Springer Nature in Microbial Cell Factories
- Vol. 25 (1)
Open AccessEfficient Escherichia coli platform for L-proline biosynthesis via systematic metabolic engineering
- 2 February 2025
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 73 (6) , 3611-3621
Efficient Escherichia coli Platform for Cannabinoid Precursor Olivetolic Acid Biosynthesis from Inexpensive Inputs
Olivetolic acid (OLA), an initial precursor of cannabinoids, is catalyzed by type III polyketide synthase, which has a wide range of pharmacological activities, such as antimicrobial and cytotoxic effects. Here, we applied systematic metabolic engineering to develop a multienzyme cascade system to produce OLA via two low-cost inputs. The polyketide synthase (OLS) and cyclase enzymes (OAC), along with the best combination of hexanoyl-CoA and malonyl-CoA synthetases (AEE3 and MatB), were first introduced into the biocatalytic system to increase the supply of hexanoyl-CoA and malonyl-CoA as starting and extender units. To drive the catalysis smoothly, an ATP regeneration system and a CoA-sufficient supply system were incorporated into the biocatalysts to provide enough cofactors. Furthermore, malonyl-CoA flux was redirected to OLA biosynthesis through delicate control of the fatty acid biosynthesis (FAB) pathway via promoter engineering. Collectively, these strategies have led us to produce OLA at a titer of 102.1 mg/L with a productivity of 25.5 mg/L/h by using malonate and hexanoate as direct substrates. Our biocatalytic system provides an effective platform for the production of the cannabinoid precursor OLA in Escherichia coli and may be a valuable reference for the development of microbial cell factories that use hexanoyl-CoA and malonyl-CoA as important intermediates.
- 2 February 2025
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 73 (6) , 3611-3621
Efficient Escherichia coli Platform for Cannabinoid Precursor Olivetolic Acid Biosynthesis from Inexpensive Inputs
Olivetolic acid (OLA), an initial precursor of cannabinoids, is catalyzed by type III polyketide synthase, which has a wide range of pharmacological activities, such as antimicrobial and cytotoxic effects. Here, we applied systematic metabolic engineering to develop a multienzyme cascade system to produce OLA via two low-cost inputs. The polyketide synthase (OLS) and cyclase enzymes (OAC), along with the best combination of hexanoyl-CoA and malonyl-CoA synthetases (AEE3 and MatB), were first introduced into the biocatalytic system to increase the supply of hexanoyl-CoA and malonyl-CoA as starting and extender units. To drive the catalysis smoothly, an ATP regeneration system and a CoA-sufficient supply system were incorporated into the biocatalysts to provide enough cofactors. Furthermore, malonyl-CoA flux was redirected to OLA biosynthesis through delicate control of the fatty acid biosynthesis (FAB) pathway via promoter engineering. Collectively, these strategies have led us to produce OLA at a titer of 102.1 mg/L with a productivity of 25.5 mg/L/h by using malonate and hexanoate as direct substrates. Our biocatalytic system provides an effective platform for the production of the cannabinoid precursor OLA in Escherichia coli and may be a valuable reference for the development of microbial cell factories that use hexanoyl-CoA and malonyl-CoA as important intermediates.
- Open Access
- 19 December 2024
- Published by Elsevier in Food Bioscience
- Vol. 63
Systematic engineering for high-level production of β-nicotinamide mononucleotide from NAM and ribose
- 19 December 2024
- Published by Elsevier in Food Bioscience
- Vol. 63
Open AccessSystematic engineering for high-level production of β-nicotinamide mononucleotide from NAM and ribose
- 7 March 2023
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 71 (11) , 4656-4664
Integrating Enzyme Evolution and Metabolic Engineering to Improve the Productivity of Γ-Aminobutyric Acid by Whole-Cell Biosynthesis in Escherichia Coli
γ-Aminobutyric acid (GABA) is used widely in various fields, such as agriculture, food, pharmaceuticals, and biobased chemicals. Based on glutamate decarboxylase (GadBM4) derived from our previous work, three mutants, GadM4-2, GadM4-8, and GadM4-31, were obtained by integrating enzyme evolution and high-throughput screening methods. The GABA productivity obtained through whole-cell bioconversion using recombinant Escherichia coli cells harboring mutant GadBM4-2 was enhanced by 20.27% compared to that of the original GadBM4. Further introduction of the central regulator GadE of the acid resistance system and the enzymes from the deoxyxylulose-5-phosphate-independent pyridoxal 5'-phosphate biosynthesis pathway resulted in a 24.92% improvement in GABA productivity, reaching 76.70 g/L/h without any cofactor addition with a greater than 99% conversion ratio. Finally, when one-step bioconversion was applied for the whole-cell catalysis in a 5 L bioreactor, the titer of GABA reached 307.5 ± 5.94 g/L with a productivity of 61.49 g/L/h by using crude l-glutamic acid (l-Glu) as the substrate. Thus, the biocatalyst constructed above combined with the whole-cell bioconversion method represents an effective approach for industrial GABA production.
- 7 March 2023
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 71 (11) , 4656-4664
Integrating Enzyme Evolution and Metabolic Engineering to Improve the Productivity of Γ-Aminobutyric Acid by Whole-Cell Biosynthesis in Escherichia Coli
γ-Aminobutyric acid (GABA) is used widely in various fields, such as agriculture, food, pharmaceuticals, and biobased chemicals. Based on glutamate decarboxylase (GadBM4) derived from our previous work, three mutants, GadM4-2, GadM4-8, and GadM4-31, were obtained by integrating enzyme evolution and high-throughput screening methods. The GABA productivity obtained through whole-cell bioconversion using recombinant Escherichia coli cells harboring mutant GadBM4-2 was enhanced by 20.27% compared to that of the original GadBM4. Further introduction of the central regulator GadE of the acid resistance system and the enzymes from the deoxyxylulose-5-phosphate-independent pyridoxal 5'-phosphate biosynthesis pathway resulted in a 24.92% improvement in GABA productivity, reaching 76.70 g/L/h without any cofactor addition with a greater than 99% conversion ratio. Finally, when one-step bioconversion was applied for the whole-cell catalysis in a 5 L bioreactor, the titer of GABA reached 307.5 ± 5.94 g/L with a productivity of 61.49 g/L/h by using crude l-glutamic acid (l-Glu) as the substrate. Thus, the biocatalyst constructed above combined with the whole-cell bioconversion method represents an effective approach for industrial GABA production.
- 30 October 2019
- Published by Walter de Gruyter GmbH in International Journal of Chemical Reactor Engineering
- Vol. 18 (1)
Antibacterial Activity of Phenyllactic acid Against Staphylococcus Epidermidis and Its Microbial Production: Modelling and Optimization-Based Analysis
Phenyllactic acid (PLA), an organic acid with extensive antimicrobial activity, is considered as a promising natural preservative to replace chemical preservatives. In order to study the inhibitory pattern of PLA, this paper established a novel mathematical model for the growth of Staphylococcus epidermidis under PLA inhibition. The simulated results showed that the relationship between the antimicrobial activity of PLA against S. epidermidis and its concentration was suitable to be represented by an exponential function. Based on the proposed model, the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) of PLA against S. epidermidis were evaluated. The computed results were found to match experimental data. The MBC value was found to be independent of the initial biomass of S. epidermidis from both the simulated results and experimental data, revealing that PLA was not consumed while killing the bacteria. Another kinetic model was established to describe the production of PLA by the engineered Escherichia coli. This model was then used to calculate the minimum biomass of E. coli to produce the MBC of PLA. The proposed models help to understand the inhibitory pattern of PLA, serving as a theoretical guide for the selection an appropriate strain to improve the product shelf-life.
- 30 October 2019
- Published by Walter de Gruyter GmbH in International Journal of Chemical Reactor Engineering
- Vol. 18 (1)
Antibacterial Activity of Phenyllactic acid Against Staphylococcus Epidermidis and Its Microbial Production: Modelling and Optimization-Based Analysis
Phenyllactic acid (PLA), an organic acid with extensive antimicrobial activity, is considered as a promising natural preservative to replace chemical preservatives. In order to study the inhibitory pattern of PLA, this paper established a novel mathematical model for the growth of Staphylococcus epidermidis under PLA inhibition. The simulated results showed that the relationship between the antimicrobial activity of PLA against S. epidermidis and its concentration was suitable to be represented by an exponential function. Based on the proposed model, the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) of PLA against S. epidermidis were evaluated. The computed results were found to match experimental data. The MBC value was found to be independent of the initial biomass of S. epidermidis from both the simulated results and experimental data, revealing that PLA was not consumed while killing the bacteria. Another kinetic model was established to describe the production of PLA by the engineered Escherichia coli. This model was then used to calculate the minimum biomass of E. coli to produce the MBC of PLA. The proposed models help to understand the inhibitory pattern of PLA, serving as a theoretical guide for the selection an appropriate strain to improve the product shelf-life.
- 4 June 2019
- Published by Wiley in Physica Status Solidi (a)
- Vol. 216 (20)
Layered MoS2 Nanosheets Fabricated by Vacuum Electron Beam Evaporation and Thickness‐Dependent Field Emission Properties
A series of 2D MoS2 nanosheet films are fabricated on Mo‐coated alumina ceramics using a vacuum electron beam vapor deposition technique. It is found that both the crystallographic orientation and the thickness of the films can be controlled well by changing the processing conditions. It is demonstrated that the thickness of the deposited MoS2 films has a direct effect on their microtopographies and field emission characteristics. For each MoS2 film, its field emission performance increases first with an increase in thickness and subsequently decreases in the examined thickness range; the best film thickness is 15 nm. All the experimental results are explained in detail.
- 4 June 2019
- Published by Wiley in Physica Status Solidi (a)
- Vol. 216 (20)
Layered MoS2 Nanosheets Fabricated by Vacuum Electron Beam Evaporation and Thickness‐Dependent Field Emission Properties
A series of 2D MoS2 nanosheet films are fabricated on Mo‐coated alumina ceramics using a vacuum electron beam vapor deposition technique. It is found that both the crystallographic orientation and the thickness of the films can be controlled well by changing the processing conditions. It is demonstrated that the thickness of the deposited MoS2 films has a direct effect on their microtopographies and field emission characteristics. For each MoS2 film, its field emission performance increases first with an increase in thickness and subsequently decreases in the examined thickness range; the best film thickness is 15 nm. All the experimental results are explained in detail.
- 7 March 2018
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 102 (8) , 3623-3633
Enhanced productivity of gamma-amino butyric acid by cascade modifications of a whole-cell biocatalyst
We previously developed a gamma-amino butyric acid (GABA)-producing strain of Escherichia coli, leading to production of 614.15 g/L GABA at 45 °C from L-glutamic acid (L-Glu) with a productivity of 40.94 g/L/h by three successive whole-cell conversion cycles. However, the increase in pH caused by the accumulation of GABA resulted in inactivation of the biocatalyst and consequently led to relatively lower productivity. In this study, by overcoming the major problem associated with the increase in pH during the production process, a more efficient biocatalyst was obtained through cascade modifications of the previously reported E. coli strain. First, we introduced four amino acid mutations to the codon-optimized GadB protein from Lactococcus lactis to shift its decarboxylation activity toward a neutral pH, resulting in 306.65 g/L of GABA with 99.14 mol% conversion yield and 69.8% increase in GABA productivity. Second, we promoted transportation of L-Glu and GABA by removing the genomic region encoding the C-plug of GadC (a glutamate/GABA antiporter) to allow its transport path to remain open at a neutral pH, which improved the GABA productivity by 16.8% with 99.3 mol% conversion of 3 M L-Glu. Third, we enhanced the expression of soluble GadB by introducing the GroESL molecular chaperones, leading to 20.2% improvement in GABA productivity, with 307.40 g/L of GABA and a 61.48 g/L/h productivity obtained in one cycle. Finally, we inhibited the degradation of GABA by inactivation of gadA and gadB from the E. coli genome, which resulted in almost no GABA degradation after 40 h. After the cascade system modifications, the engineered recombinant E. coli strain achieved a 44.04 g/L/h productivity with a 99.6 mol% conversion of 3 M L-Glu in a 5-L bioreactor, about twofold increase in productivity compared to the starting strain. This increase represents the highest GABA productivity by whole-cell bioconversion using L-Glu as a substrate in one cycle observed to date, even better than the productivity obtained from the three successive conversion cycles.
- 7 March 2018
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 102 (8) , 3623-3633
Enhanced productivity of gamma-amino butyric acid by cascade modifications of a whole-cell biocatalyst
We previously developed a gamma-amino butyric acid (GABA)-producing strain of Escherichia coli, leading to production of 614.15 g/L GABA at 45 °C from L-glutamic acid (L-Glu) with a productivity of 40.94 g/L/h by three successive whole-cell conversion cycles. However, the increase in pH caused by the accumulation of GABA resulted in inactivation of the biocatalyst and consequently led to relatively lower productivity. In this study, by overcoming the major problem associated with the increase in pH during the production process, a more efficient biocatalyst was obtained through cascade modifications of the previously reported E. coli strain. First, we introduced four amino acid mutations to the codon-optimized GadB protein from Lactococcus lactis to shift its decarboxylation activity toward a neutral pH, resulting in 306.65 g/L of GABA with 99.14 mol% conversion yield and 69.8% increase in GABA productivity. Second, we promoted transportation of L-Glu and GABA by removing the genomic region encoding the C-plug of GadC (a glutamate/GABA antiporter) to allow its transport path to remain open at a neutral pH, which improved the GABA productivity by 16.8% with 99.3 mol% conversion of 3 M L-Glu. Third, we enhanced the expression of soluble GadB by introducing the GroESL molecular chaperones, leading to 20.2% improvement in GABA productivity, with 307.40 g/L of GABA and a 61.48 g/L/h productivity obtained in one cycle. Finally, we inhibited the degradation of GABA by inactivation of gadA and gadB from the E. coli genome, which resulted in almost no GABA degradation after 40 h. After the cascade system modifications, the engineered recombinant E. coli strain achieved a 44.04 g/L/h productivity with a 99.6 mol% conversion of 3 M L-Glu in a 5-L bioreactor, about twofold increase in productivity compared to the starting strain. This increase represents the highest GABA productivity by whole-cell bioconversion using L-Glu as a substrate in one cycle observed to date, even better than the productivity obtained from the three successive conversion cycles.
- Open Access
- 6 March 2018
- Published by Taylor & Francis in Biotechnology & Biotechnological Equipment
- Vol. 32 (3) , 566-573
Efficient gamma-aminobutyric acid bioconversion by engineered Escherichia coli
Gamma-aminobutyric acid (GABA) can be converted into 2-pyrrolidone, an intermediate in the synthesis of nylon 4 and agrochemicals, which has great potential for application in the chemical industry. The main aim of this work was to construct a simple and efficient process for industrial production of GABA from L-glutamic acid (L-Glu) by whole-cell bioconversion. The gene encoding glutamate decarboxylase (GAD) from Lactococcus lactis FJNUGA01 was overexpressed using the most available vector in Escherichia coli, pET-28a. GABA production was enhanced by optimizing the concentration of the catalyst isopropyl-β-D-thiogalactoside (IPTG), induction temperature and induction time. After optimization, GABA production reached 98.4 g L−1 with 96 mol% conversion within 6 h was achieved by whole-cell conversion using the cells induced with 1 mmol L−1 IPTG for 12 h at 30 °C. Furthermore, when the initial concentration of L-Glu was adjusted, 204.12 g L−1 GABA with 34 g L−1 h−1 productivity was reached using 2 mol L−1 L-Glu as the substrate. During the 6 h whole-cell bioconversion process, almost all L-Glu was converted to GABA with a conversion efficiency of ∼99%. The high conversion efficiency and high productivity made the GABA purification occur downstream, and the whole process is more simple and economical for industrial application.
- 6 March 2018
- Published by Taylor & Francis in Biotechnology & Biotechnological Equipment
- Vol. 32 (3) , 566-573
Open AccessEfficient gamma-aminobutyric acid bioconversion by engineered Escherichia coli
Gamma-aminobutyric acid (GABA) can be converted into 2-pyrrolidone, an intermediate in the synthesis of nylon 4 and agrochemicals, which has great potential for application in the chemical industry. The main aim of this work was to construct a simple and efficient process for industrial production of GABA from L-glutamic acid (L-Glu) by whole-cell bioconversion. The gene encoding glutamate decarboxylase (GAD) from Lactococcus lactis FJNUGA01 was overexpressed using the most available vector in Escherichia coli, pET-28a. GABA production was enhanced by optimizing the concentration of the catalyst isopropyl-β-D-thiogalactoside (IPTG), induction temperature and induction time. After optimization, GABA production reached 98.4 g L−1 with 96 mol% conversion within 6 h was achieved by whole-cell conversion using the cells induced with 1 mmol L−1 IPTG for 12 h at 30 °C. Furthermore, when the initial concentration of L-Glu was adjusted, 204.12 g L−1 GABA with 34 g L−1 h−1 productivity was reached using 2 mol L−1 L-Glu as the substrate. During the 6 h whole-cell bioconversion process, almost all L-Glu was converted to GABA with a conversion efficiency of ∼99%. The high conversion efficiency and high productivity made the GABA purification occur downstream, and the whole process is more simple and economical for industrial application.